APA (7th ed.) Citation

FF, S., DF, L., LB, K., JL, L., SL, M., HZ, J., . . . JT, Z. (2026). ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis. Frontiers in immunology, 17, 1752827. https://doi.org/10.3389/fimmu.2026.1752827

Chicago Style (17th ed.) Citation

FF, Shen, et al. "ADAMTS9-AS2 Acts as an Epigenetic Brake to Constrain DNMT3B-mediated CADM2 Silencing in Esophageal Squamous Cell Carcinoma Metastasis." Frontiers in Immunology 17 (2026): 1752827. https://doi.org/10.3389/fimmu.2026.1752827.

MLA (9th ed.) Citation

FF, Shen, et al. "ADAMTS9-AS2 Acts as an Epigenetic Brake to Constrain DNMT3B-mediated CADM2 Silencing in Esophageal Squamous Cell Carcinoma Metastasis." Frontiers in Immunology, vol. 17, 2026, p. 1752827, https://doi.org/10.3389/fimmu.2026.1752827.